Jennifer Yoo advises clients active in the healthcare and healthtech sectors on complex regulatory and transactional matters.
Jennifer draws on deep regulatory knowledge to counsel public and private companies and investors, including venture capital funds, private equity firms, and underwriters. She helps clients navigate a rapidly evolving healthcare landscape, in particular where new technology and ever-shifting regulations push stakeholders to move at the pace of innovation. She regularly advises clients on matters involving:
- Healthcare fraud and abuse, including federal and state anti-kickback, false claims, and Stark Law compliance
- Digital health, telehealth/teleprescribing, and direct-to-consumer health and wellness offerings
- AI and machine learning in technology-enabled healthcare delivery
- Strategic counseling for healthcare businesses subject to the Corporate Practice of Medicine doctrine and related fee-splitting regulations for physician and other licensed healthcare professional services
- Reimbursement strategy and counseling, including on innovative payment models
- HIPAA and state consumer health data privacy compliance
Jennifer provides strategic regulatory counsel in connection with corporate transactions, including mergers, acquisitions, joint ventures, financings, and securities offerings. She helps clients evaluate regulatory risks associated with investments in healthtech and life sciences companies.
A trusted strategic advisor, Jennifer also provides litigation support for healthcare-related matters, including white collar defense, government investigations, compliance audits, internal investigations, and voluntary disclosures.
Before joining Latham, Jennifer was a partner at another global law firm. She previously served as counsel in Latham’s Los Angeles office from 2019 to 2022 and as an associate from 2007 to 2019.